Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2647 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-03-21 (news-pharm.ru)
Western pharmaceutical companies made large -scale personnel contractions ⋆
Recently, pharmaceutical companies Moderna, Biogen and J& J have significantly reduced the number of staff. Last year, the total number of people who lost
Read more
2025-03-20 (biospace.com)
Spinal muscular atrophy -
In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of its Ionis-partnered therapy Spinraza for spinal muscular atrophy will be considered by the FDA and EMA.
Read more
2025-02-13 (endpts.com)
Biogen downplays capacity for M&A; Roche's SMA drug is approved as a tablet
Biotech news roundup: Odyssey layoffs, GSK relocates vaccine R&D, Aligos raises $105M, Terrain Bio launches, Gates Foundation backs antibiotics research, Neuphoria gets Merck milestone
Read more
2024-12-13 (devdiscourse.com)
Health Industry Headlines: Medicare Coverage, Vaccination Plans, and Market Movements | Health
Recent health news highlights Biogen's ALS drug coverage for Medicare plans, discussions on ending childhood vaccination programs, and label updates for Novo Nordisk's Ozempic. Additionally, concerns over Intercept's liver drug, tax credit expectations under Trump, job cuts at Editas Medicine, and Congo's mpox vaccine reception are noted.
Read more
2024-10-26 (nau.ch)
Biogen is cutting 95 more jobs in Baar ZG
The pharmaceutical giant Biogen will cut 95 of the 500 jobs in Baar ZG. It is unclear how many employees can be taken on in other roles.
Read more
2024-10-25 (luzernerzeitung.ch)
Job cuts: Biogen has to lay off staff again in Baar
The last discussions with the employees were concluded on Thursday, says a spokeswoman. It is currently unclear how many will be laid off.
Read more
2024-10-25 (agefi.com)
Biogen would cut nearly 100 jobs in Switzerland
Biogen Suisse would reduce its workforce, the “Inside Paradeplatz” website understands. Biotech would eliminate 95 of the 1,000 jobs it has in Switzerland.
Read more
2024-10-22 (benzinga.com)
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce - Sage Therapeutics (NASDAQ:SAGE), Biogen (NASDAQ:BIIB)
Sage Therapeutics announces reorganization, including layoffs and pipeline changes, to support the launch of Zurzuvae. Focus shifts to Huntington's Disease trial after setbacks in essential tremor and Alzheimer's treatments.
Read more
2024-10-20 (medicaldialogues.in)
Sage Therapeutics reshuffles leadership, cuts 165 jobs to focus on postpartum depression drug launch
The drugmaker plans to prioritize the launch of its postpartum depression pill Zurzuvae, that has been jointly developed with Biogen.
Read more